+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Galantamine"

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • December 2024
  • 125 Pages
  • Global
From
From
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Alzheimer's Drugs Market Report 2025 - Product Thumbnail Image

Alzheimer's Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 240 Pages
  • Global
From
From
Alzheimer's Disease - Pipeline Insights, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insights, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
Alzheimer's Therapeutics Market Report 2022-2032 - Product Thumbnail Image

Alzheimer's Therapeutics Market Report 2022-2032

  • Report
  • December 2022
  • 196 Pages
  • Global
From
From
From
Alzheimer's Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Alzheimer's Disease Market and Forecast Analysis 2034 - Product Thumbnail Image

Alzheimer's Disease Market and Forecast Analysis 2034

  • Drug Pipelines
  • February 2019
  • 300 Pages
  • Global
From
Loading Indicator

Galantamine is a drug used to treat mild to moderate Alzheimer's Disease. It is an acetylcholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory, thinking, and behavior in people with Alzheimer's. Galantamine is available in both oral and intravenous forms, and is often used in combination with other Alzheimer's medications. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. Galantamine is one of several drugs used to treat Alzheimer's Disease, and is often prescribed alongside other medications such as donepezil and memantine. It is available in generic form, as well as under the brand names Razadyne and Reminyl. Companies in the Galantamine market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more